EFPIA Laments 'Unfortunate' Exclusions From ICH Guide On Nonclinical Pediatric Safety
Executive Summary
Europe’s research-based pharmaceutical industry has suggested changes to the draft ICH S11 guideline on nonclinical safety studies for supporting pediatric development programs.
You may also be interested in...
ICH Guide Aims To Facilitate Pediatric Trials And Reduce Animal Testing
A new international guideline on non-clinical safety testing in support of pediatric drug development aims to cut unnecessary use of animals.
New ICH Guide To Eliminate ‘Discordant Advice’ On Juvenile Animal Studies
Experts at the International Council for Harmonisation have nearly completed the first draft of a guideline that explains in which situations nonclinical juvenile animal testing is considered informative and necessary to support pediatric drug development. The guideline is expected to address the "discordant advice" that different regulatory agencies currently offer companies in relation to such studies.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.